Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
25.35 USD | +1.44% | +0.68% | -62.29% |
30/04 | Medifast Shares Drop as Q1 Adjusted Earnings, Revenue Decline; Sets Q2 Guidance | MT |
30/04 | Wall Street Poised for Cautious Day Ahead of Key Numbers, Earnings, Fed Report | MT |
Sales 2024 * | 65Cr 5.4TCr | Sales 2025 * | 66Cr 5.53TCr | Capitalization | 27Cr 2.23TCr |
---|---|---|---|---|---|
Net income 2024 * | 90L 75Cr | Net income 2025 * | 2Cr 166.97Cr | EV / Sales 2024 * | 0.14 x |
Net cash position 2024 * | 18Cr 1.49TCr | Net cash position 2025 * | 22Cr 1.82TCr | EV / Sales 2025 * | 0.07 x |
P/E ratio 2024 * |
28.7
x | P/E ratio 2025 * |
13.2
x | Employees | 634 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.31% |
Latest transcript on Medifast, Inc.
1 day | +1.44% | ||
1 week | +0.68% | ||
Current month | -7.92% | ||
1 month | -19.55% | ||
3 months | -52.06% | ||
6 months | -59.22% | ||
Current year | -62.29% |
Managers | Title | Age | Since |
---|---|---|---|
Daniel Chard
CEO | Chief Executive Officer | 59 | 03/16/03 |
James Maloney
DFI | Director of Finance/CFO | 56 | 20/20/20 |
Anthony Tyree
COO | Chief Operating Officer | 58 | 01/18/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Daniel Chard
CEO | Chief Executive Officer | 59 | 03/16/03 |
Jeffrey Brown
BRD | Director/Board Member | 63 | 17/15/17 |
Andrea B. Thomas
BRD | Director/Board Member | 59 | 12/19/12 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.42% | 25 M€ | -2.33% | - |
Date | Price | Change | Volume |
---|---|---|---|
13/24/13 | 25.35 | +1.44% | 452,901 |
10/24/10 | 24.99 | -2.84% | 275,198 |
09/24/09 | 25.72 | +3.04% | 338,668 |
08/24/08 | 24.96 | -2.16% | 336,907 |
07/24/07 | 25.51 | +1.31% | 512,078 |
Delayed Quote Nyse, May 14, 2024 at 01:30 am IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-62.29% | 27Cr | |
+17.10% | 842.63Cr | |
+14.30% | 682.32Cr | |
-3.69% | 377.06Cr | |
-7.34% | 373.8Cr | |
+1.78% | 143.93Cr | |
-28.77% | 106.27Cr | |
+18.84% | 104.02Cr | |
-11.81% | 89Cr | |
-18.34% | 81Cr |
- Stock Market
- Equities
- MED Stock